Skip to main content
Back
Watch Compare

BIOVIE INC.

Data quality: 83%
Also listed as BIVIW NASDAQ
BIVI
NASDAQ Manufacturing Chemicals
$1.35
▼ $0.09 (-6.25%)
Mkt Cap: 10.18 M
Price
$1.35
Mkt Cap
10.18 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -14.32 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-74.68%
Below sector avg (-54.44%)
ROIC-64.36%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio7.25
Interest Coverage-2287.35

Valuation

PE (TTM)
-0.62
Above sector avg (-1.49)
P/B Ratio0.53
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.6 -1.5
P/B 0.5 1.6
ROE % -74.7 -54.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 — 0.0 —

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$0.79 -$0.98 -24.1%
Q22025 -$3.60 -$11.05 -206.9%
Q12025 -$3.20 -$1.50 +53.1%
Q42024 N/A -$4.60 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -16.50 M
ROE -74.68% ROA -66.90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -14.32 M
ROIC -64.36% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.25
Interest Coverage -2287.35 Asset Turnover N/A
Working Capital 18.79 M Tangible Book Value 18.86 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.62 Forward P/E N/A
P/B Ratio 0.53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -140.69%
Market Cap 10.18 M Enterprise Value -10.36 M
Per Share
EPS (Diluted TTM) -12.77 Revenue / Share N/A
FCF / Share -1.90 OCF / Share -1.90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.81%
SBC-Adj. FCF -15.41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -17.54 M -32.12 M -50.26 M -26.08 M -130.25 M
EPS (Diluted) -12.12 -7.30 -1.55 -1.06 -14.82
Gross Profit — — — — —
Operating Income -18.07 M -32.18 M -45.08 M -27.25 M -138.05 M
EBITDA — — — — —
R&D Expenses 9.27 M 23.10 M 33.30 M 17.26 M 133.19 M
SG&A Expenses 8.57 M 8.85 M 11.55 M 9.77 M 4.64 M
D&A — — — — —
Interest Expense 312,000.0 2.89 M 4.30 M 2.16 M 559,455.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21.56 M 25.21 M 35.10 M 20.11 M 6.05 M
Total Liabilities 2.55 M 9.70 M 19.76 M 16.44 M 996,374.0
Shareholders' Equity 19.01 M 15.51 M 15.34 M 3.67 M 5.05 M
Total Debt — — — — 62,500.0
Cash & Equivalents 17.54 M 23.84 M 19.46 M — —
Current Assets 20.70 M 24.05 M 34.04 M 18.78 M 4.61 M
Current Liabilities 2.27 M 9.35 M 14.49 M 4.17 M 996,374.0